stockrowLantheus Holdings, Inc.
LNTH Healthcare Drug Manufacturers Specialty & Generic
Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024.
- Revenue
- +1.54%
- EPS
- −17.1%
- Free cash flow
- +7.71%
- Total debt
- +0.52%
Quarter to September 2026, against a year earlier
Follow LNTH
Alert me
Lantheus Holdings, Inc. (LNTH) Gross margin
Lantheus Holdings, Inc.'s gross margin over the twelve months to 30 September 2026 was 61.3%, up 0.2 percentage points from fiscal 2025 (61.1%). Over the past ten years it has ranged from 40.9% (fiscal 2020) to 64.4% (fiscal 2024); the current reading is higher than 82% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 53.5% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 61.1% | (3.33) |
| FY2024 | 64.4% | 9.70 |
| FY2023 | 54.7% | (7.48) |
| FY2022 | 62.2% | 18.07 |
| FY2021 | 44.1% | 3.26 |
| FY2020 | 40.9% | (9.45) |
| FY2019 | 50.3% | (0.60) |
| FY2018 | 50.9% | 2.00 |
| FY2017 | 48.9% | 3.29 |
| FY2016 | 45.6% | (0.54) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 62.4% | 0.13 |
| Jun 2026 | 62.3% | 1.10 |
| Mar 2026 | 61.2% | 1.99 |
| Dec 2025 | 59.2% | 1.30 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| LQDA Liquidia Corporation compare | 92.5% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 90.2% |
| SUPN Indivior Pharmaceuticals Inc. compare | 84.9% |
| ALKS Alkermes plc compare | 82.9% |
| HIMS Hims & Hers Health, Inc. compare | 68.4% |
| LNTH Lantheus Holdings, Inc. | 61.3% |
| RDY Dr. Reddy's Laboratories Ltd compare | 49.2% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 40.2% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −42.7% |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on LNTH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement